292
Views
38
CrossRef citations to date
0
Altmetric
Brief Report

Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003–2004

&
Pages 49-56 | Accepted 23 Oct 2006, Published online: 01 Dec 2006

References

  • Patel NC, Sanchez RJ, Johnsrud MT, et al. Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996 to 2000. J Child Adolesc Psychopharmacol 2002;12:221–9
  • Aparasu R, Bhatara V. Antipsychotic prescribing trends in children and adolescents, 1997–2002. Psychiatric Serv 2005;56:904
  • Patel NC, Crismon ML, Hoagwood K, et al. Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry 2005;44:548–56
  • Cooper WO, Arbogast PG, Ding H, et al. Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr 2006;6:79–83
  • Patel NC, Crismon ML, Shafer A. Diagnoses and antipsychotic treatment among youths in a public mental health system. Ann Pharmacother 2006;40:205–11
  • Patel NC, Crismon ML, Hoagwood K, et al. Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program. Med Care 2006;44:87–90
  • Olfson M, Blanco C, Liu L, et al. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006;63:679–85
  • Cheng-Shannon J, McGough J, Pataki C, et al. Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacology 2004;14:372–94
  • Findling RL, Steiner H, Weller EB. Use of antipsychotics in children and adolescents. J Clin Psychiatry 2005; 66s:29–40
  • Bhatara V, Lopez-Munoz F, Gupta S. Celebrating the 50th anniversary of the introduction of chlorpromazine in North America and the advent of the psychopharmacology revolution. Ann Clin Psychiatry 2005;17:109–11
  • Curtis LH, Masselink LE, Ostbye T, et al. Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Arch Pediatr Adolesc Med 2005;159:362–6
  • National Center for Health Statistics. National Ambulatory Medical Care Survey. Hyattsville, MD: United States Department of Health and Human Services, National Center for Health Statistics. Documentation available from ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS/ [Last accessed 13 Oct 2006]
  • National Center for Health Statistics. National Hospital Ambulatory Medical Care Survey. Hyattsville, MD: United States Department of Health and Human Services, National Center for Health Statistics. Documentation available from ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHAMCS/ [Last accessed 13 Oct 2006]
  • Andersen RM. A behavioral model of families’ use of health services. (Research Series 25). Center for Health Administration Studies Chicago: University of Chicago, 1968
  • Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995;36:1–10
  • US Department of Health and Human Services. Centers for Disease Control and Prevention. Health Care Financing Administration. International Classification of Diseases, 9th Revision, Clinical Modification. 6th edn. 2004
  • Koch H, Campbell W. The collection and processing of drug information. National Center for Health Statistics. Vital Health Stat 2 1982;90:1–90
  • Van Brunt DL, Gibson PJ, Ramsey JL, et al. Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1997–2000. Med Gen Med 2003;5:16
  • Hing E, Gousen S, Shimizu I, et al. Guide to using masked design variables to estimate standard errors in public use files of the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Inquiry 2003;40:401–15
  • Aparasu R, Bhatara V, Gupta S. U.S. National trends in the use of antipsychotics during office visits, 1998–2002. Ann Clin Psychiatry 2005:17: 147–52
  • Bagnall AM, Jones L, Ginnelly L, et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 2003;7:1–193
  • Patel NC, Crismon ML, Hoagwood K, et al. Unanswered questions regarding atypical antipsychotic use in aggressive children and adolescents. J Child Adolesc Psychopharmacol 2005;15:270–84
  • Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;22;1209–23
  • Lieberman J, Stroup S, McEvoy J, et al. Effectiveness of anti-psychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–23
  • Correll CU. Metabolic side effects of second-generation anti-psychotics in children and adolescents: a different story? J Clin Psychiatry 2005;66:1331–2
  • Zito JM, Safer DJ. Recent child pharmacoepidemiological findings. J Child Adolesc Psychopharmacol 2005;15:5–9
  • Kowatch RA, Fristad M, Birmaher B, et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005;44:213–35
  • Post RM, Kowatch RA. The health care crisis of childhood-onset bipolar disorder: some recommendations for its amelioration. J Clin Psychiatry 2006;67:115–25
  • Thomas CP, Conrad P, Casler R, et al. Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatr Serv 2006;57:63–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.